Video screenshot of Dr. Siegel.
Featured Patient Story

Dr. Siegel's Story

Dr. Siegel is a urologist and the former CEO of Chesapeake Urology. He has been treating men with prostate cancer for over 30 years, but then he was diagnosed. Hear from him and his medical team, Dr. Sigman and Dr. Brookland, about how they determined the best treatment for Dr. Siegel, which included hormone and radiation therapy along with SpaceOAR Hydrogel.

Patient Stories

Read Article

Henry's Story

When Henry was diagnosed with prostate cancer, his greatest fear was a diminishment of any aspect of his life. Learn how radiation therapy and SpaceOAR Hydrogel helped him avoid that.

Read More
Watch Video

An interview with SpaceOAR Hydrogel Patient — Alan

Alan had several encounters with prostate cancer through friends and family, and due to his family history, there was a higher likelihood that he’d encounter it as well. After monitoring PSA levels for years, Alan was eventually diagnosed with prostate cancer. Watch his story about how he faced the disease.
Read Article

An interview with SpaceOAR Hydrogel Patient — Pierre

Pierre, an 81-year-old from Texas was a former state champion in judo from age 64–66. When he was originally diagnosed with prostate cancer his first thought was to get a prostatectomy, but after doing research he decided brachytherapy and external beam radiation along with SpaceOAR Hydrogel was the best option.

Read More
Read Article

Ron's Story

"Get SpaceOAR Hydrogel. It allows the physician to optimally treat patients so that the surrounding organs around the prostate are protected from radiation. Also, keep your body strong and be sure to exercise."

Read More
Read Article

Manuel's Story

In 2018 during an annual physical, Manuel's primary care physician discovered he had a high PSA. He was scheduled for a biopsy, which is when his oncologist discovered that he had stage 4 prostate cancer.

Read More
Read Article

Steve's Story

Steve seemed to have it all. After a career in the U.S. Navy, he and his wife of 38 years were living in St. Johns, Florida, enjoying life with their two sons. Hear Steve's treatment journey with radiation therapy for prostate cancer, and why he had SpaceOAR Hydrogel.

Read More

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary. Content of this video is for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

SpaceOAR Hydrogel is intended to temporarily move the rectal wall away from the prostate during the course of radiotherapy treatment for prostate cancer, and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose affecting the rectum.

SpaceOAR Hydrogel contains polyethylene glycol (PEG). As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a hole between rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, rectum), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel. If one or more of these complications occur, you may need medical treatment or surgery. URO-1288805-AA

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-709404-AB FEB 2023